Dopamine, hypertension and obesity

Area of Science:

• Neuroscience
• Pharmacology
• Cardiovascular Physiology

Background:

• Dopamine is a key neurotransmitter and precursor to noradrenaline.
• It regulates cardiovascular and renal functions, including myocardial contractility, cardiac output, vasodilation, diuresis, and natriuresis.
• These actions are mediated by dopamine receptors D(1) through D(5), with potential D(6) and D(7) receptors under investigation.

Purpose of the Study:

• To elucidate the physiological and pharmacological aspects of dopamine and its receptors.
• To explore the potential clinical applications of dopamine and its derivatives in treating arterial hypertension.
• To investigate the role of dopamine in obesity, particularly the association with D(2) receptor expression.

Main Methods:

• Review of physiological and pharmacological actions of dopamine.
• Analysis of dopamine receptor interactions.
• Examination of existing evidence on dopamine's effects on arterial pressure and obesity.

Main Results:

• Dopamine influences arterial pressure via central and peripheral nervous systems and target organs.
• Dopamine and its derivatives exhibit potential antihypertensive effects, though further study is needed.
• Obesity is associated with decreased brain expression of dopamine D(2) receptors.

Conclusions:

• Dopamine plays a significant role in cardiovascular and renal regulation.
• Dopamine receptor interactions are crucial for its physiological effects.
• Further research into dopamine's therapeutic potential for hypertension and obesity is warranted, especially concerning D(2) receptor function.